Bone targeted nanoparticles to restore acute myeloid leukemia (AML) marrow niche

Last updated 5th Jul 2017
Follow pinboard

CURATOR

A pinboard by Marian Ackun-Farmmer

Graduate Student, University of Rochester

PINBOARD SUMMARY

Approximately 20,000 children and adults are diagnosed with acute myeloid leukemia (AML) each year with associated direct and indirect healthcare costs of >16 billion dollars. Although multiple ...

9 ITEMS PINNED

#1
patent-icon
Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 ga...
Free access available
Research published 19th Dec 2015 in Biochimica ...
Pinned 5th Jul 2017
#2
patent-icon
Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphata...
Free access available
Research published 23rd Oct 2015 in Journal of ...
Pinned 5th Jul 2017
#3
patent-icon
FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice.
Free access available
Research published 26th Jun 2015 in Leukemia
Pinned 5th Jul 2017
#4
patent-icon
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts.
Free access available
Research published 21st Aug 2014 in Blood
Pinned 5th Jul 2017
Followers (0)
Share
Pinboard URL (click to copy)
Embed on website (click to copy)